{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE173nnn/GSE173247/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE173247"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"AVIL is a bona fide oncogene in rhabdomyosarcoma","description":"1. AVIL forms a protein-coding fusion with MARS in rhabdomyosarcoma. 2. AVIL is amplified in some RMSs, and overexpressed in most of the RMSs we tested. 3. Tumor cells are addicted to the MARS-AVIL fusion or overexpression of AVIL. 4. Higher AVIL expression correlates with poor prognosis in sarcoma patients","dates":{"publication":"2026/05/28"},"accession":"GSE173247","cross_references":{"GSM":["GSM5264277","GSM5264278","GSM5264276"],"GPL":["24676"],"SRA":["SRP316187"],"GSE":["173247"],"taxon":["Homo sapiens"]}}